Dr. Leandro Brust
About Dr. Leandro Brust
Dr. Leandro Brust serves as a Principal Investigator at multiple pharmaceutical companies in Lajeado, Brazil, with extensive experience in oncology and clinical research. He has contributed to various studies and has a strong academic background in medicine and health economics.
Current Role at Janssen Inc.
Dr. Leandro Brust serves as Investigador Principal at Janssen Inc. since 2017. His role involves leading clinical research initiatives in Lajeado e Região, Brasil. He has been instrumental in various studies aimed at evaluating the efficacy and safety of new therapeutic approaches.
Experience at Regeneron Pharmaceuticals
Dr. Brust worked as Investigador Principal at Regeneron Pharmaceuticals, Inc. for 11 months in 2018. His contributions during this period focused on advancing clinical trials and enhancing the understanding of treatment options within the pharmaceutical landscape.
Educational Background
Dr. Brust holds a Doctorate in Biotechnology from Universidade de Caxias do Sul, where he focused on autophagy and apoptosis in Saccharomyces cerevisiae. He also completed an MBA in Financial Management, Auditing, and Controllership at Fundação Getulio Vargas, and has pursued various specialized courses in health management and project management.
Founding of Molecular Diagnostics CYTOGENE
In 2013, Dr. Brust founded Molecular Diagnostics CYTOGENE, which specialized in personalized medicine and pharmacogenomics. This venture was later acquired by DASA, showcasing his commitment to advancing healthcare through innovative diagnostic solutions.
Contributions to Medical Education
Dr. Brust has played a significant role in the development of the medical school at Centro Universitário Univates. His efforts contributed to the institution's recognition as the top medical school in Rio Grande do Sul outside the capital, reflecting his dedication to medical education and training.